Copper chelates as possible active forms of the antiarthritic agents.
D000085:Acetates / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use* / Q000633:toxicity; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002614:Chelating Agents / Q000627:therapeutic use* / Q000633:toxicity; D003300:Copper / Q000627:therapeutic use* / Q000633:toxicity; D004195:Disease Models, Animal; D004487:Edema / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D006854:Hydrocortisone / Q000627:therapeutic use; D007928:Lethal Dose 50; D051379:Mice; D051381:Rats; D012459:Salicylates / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use; D014456:Ulcer / Q000188:drug therapy; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D000085:Acetates; D000893:Anti-Inflammatory Agents; D002614:Chelating Agents; D012459:Salicylates; D062367:ortho-Aminobenzoates; D003300:Copper; D014364:Tryptophan; D006854:Hydrocortisone